Home » Newsletters » BioWorld Science

BioWorld Science

March 21, 2007

View Archived Issues

Antiproliferative effect of eicosapentaenoic acid reported in pancreatic cancer cells

Snapshots: The American Society for Clinical Pharmacology and Therapeutics meeting

ATC reduces replication of HIV virus in patients with drug-resistant disease

Corlux shows correlation between plasma levels and clinical outcome in PMD

First results show AGI-1067 did not meet primary endpoint of ARISE trial

Vascular Wrap Paclitaxel-Eluting Mesh begins U.S. pivotal study

New collaboration for development of IV Artesunate

Enrollment begins in phase II trials of Vascugel

Chromos proposing collaboration for CHR-1103

Enrollment completed in final phase III study for ferumoxytol

POT-4 enters clinical development for AMD

New vaccine approach for the treatment of Alzheimer's disease

NKDCs suggested as a candidate immunotherapy for lung metastases

Multimodal therapy with TNFerade suggested for cholangiocarcinoma

Natural fungal product shows antimyeloma activity in vitro and in vivo

NAP reduces tau hyperphosphorylation in vivo

Bevacizumab/rapamycin combination effective in managing peritoneal disease from ovarian cancer

Novel radiolabeled Affibody conjugate shows antitumor efficacy in vivo

Novel drug promotes differentiation of neural stem cells via modulation of the Notch/Hes pathway

IND for second siRNA therapeutic based on SR Pharma chemistry

Ramelteon filed in E.U. for primary insomnia

Takeda warns on increased risk of fractures associated with pioglitazone

FDA approves Keppra for primary generalized tonic-clonic seizures

Approvable letter for Prograf plus MMF in kidney transplant patients

Recent patents disclose novel therapeutic agents for respiratory disorders

Recent patents cover new therapeutic agents for nutritional disorders such as obesity

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 8, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
ASCO 2026: Chinese biopharma arrives at ASCO with pivotal wins
BioWorld
If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s...
Bial-Portela discovers new OX1 receptor antagonists
BioWorld Science
Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...
Autobahn on the fast track with bipolar thyroid agonist
BioWorld
Achieving high marks in the phase II Amplify-BD trial for bipolar I and II depression, Autobahn Therapeutics Inc.’s elunetirom, a brain-penetrant central nervous...